The desire for expanded telehealth options has surged since the onset of the pandemic. To address the increased demand for care flexibility and access, hospitals, health systems and healthcare companies have significantly broadened their suite of telehealth solutions in recent years.
Cleveland Clinic Innovations portfolio company, Xealth, launches Dewey, which calculates engagement benchmarks from nearly 1000 use cases across more than 400 hospitals.
Masimo, a leading global provider of medical technology and hospital automation solutions, and Cleveland Clinic announced the launch of a new partnership centered around hospital-based remote patient monitoring (RPM), including TeleCritical Care.
In a rapidly evolving medical landscape, Dr. Charles “Chuck” Martin III, MD, a Cleveland Clinic inventor, sheds light on the transformative potential of augmented reality (AR) and other advanced imaging technologies in medical practice.
Developed through an ongoing collaboration with the augmented reality (AR) software developer MediView, the OmnifyXR system includes a wearable heads-up display capable of showing up to four different information feeds at once.
Joe Rich of Cleveland Clinic Innovations joins other Cleveland area thought leaders to discuss the future of the Cleveland Innovation District.
In the Cleveland Clinic Innovations profile series, members of the Innovations team share their journey to joining the Innovations department at Cleveland Clinic, what they find inspiring about their role, and what innovation means to them.
Cleveland Clinic recognized as one of the most innovative health systems.
Dr. Margot Damaser’s new device improves on her “Fitness tracker for the bladder” and measures both pressure and volume in preclinical models. Her milestone 200th paper was published in IEEE Sensors Journal. The Urodynamics Monitor (UM) was developed with support from Cleveland Clinic Innovations.
Company currently collaborates with Cleveland Clinic on breast cancer and ovarian cancer vaccines. The research under the new joint development agreement will be led at Cleveland Clinic by Thaddeus Stappenbeck, MD, PhD, Department Chair of Inflammation and Immunity.